HRP20110883T1 - Postupak za pripremanje raspršivanjem osušenih formulacija tmc125 - Google Patents

Postupak za pripremanje raspršivanjem osušenih formulacija tmc125 Download PDF

Info

Publication number
HRP20110883T1
HRP20110883T1 HR20110883T HRP20110883T HRP20110883T1 HR P20110883 T1 HRP20110883 T1 HR P20110883T1 HR 20110883 T HR20110883 T HR 20110883T HR P20110883 T HRP20110883 T HR P20110883T HR P20110883 T1 HRP20110883 T1 HR P20110883T1
Authority
HR
Croatia
Prior art keywords
tmc125
polymer
microcrystalline cellulose
weight ratio
charge
Prior art date
Application number
HR20110883T
Other languages
English (en)
Croatian (hr)
Inventor
Rene Irene Kiekens Filip
Firmin Marceline Voorspoels Jody
Elvire Colette Baert Lieven
Original Assignee
Tibotec Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37179187&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20110883(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tibotec Pharmaceuticals filed Critical Tibotec Pharmaceuticals
Publication of HRP20110883T1 publication Critical patent/HRP20110883T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR20110883T 2006-06-06 2007-06-06 Postupak za pripremanje raspršivanjem osušenih formulacija tmc125 HRP20110883T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06115029 2006-06-06
PCT/EP2007/055607 WO2007141308A1 (en) 2006-06-06 2007-06-06 Process for preparing spray dried formulations of tmc125

Publications (1)

Publication Number Publication Date
HRP20110883T1 true HRP20110883T1 (hr) 2012-01-31

Family

ID=37179187

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110883T HRP20110883T1 (hr) 2006-06-06 2007-06-06 Postupak za pripremanje raspršivanjem osušenih formulacija tmc125

Country Status (26)

Country Link
US (2) US20090197903A1 (pt)
EP (1) EP2029110B1 (pt)
JP (1) JP5089685B2 (pt)
KR (1) KR101179905B1 (pt)
CN (1) CN101453989B (pt)
AT (1) ATE522202T1 (pt)
AU (1) AU2007255418C1 (pt)
BR (1) BRPI0712346B8 (pt)
CA (1) CA2651665C (pt)
CY (1) CY1112154T1 (pt)
DK (1) DK2029110T3 (pt)
EC (1) ECSP088938A (pt)
ES (1) ES2372983T3 (pt)
HR (1) HRP20110883T1 (pt)
IL (1) IL195710A (pt)
ME (1) ME01305B (pt)
MX (1) MX2008015686A (pt)
NO (1) NO343652B1 (pt)
NZ (1) NZ572702A (pt)
PL (1) PL2029110T3 (pt)
PT (1) PT2029110E (pt)
RS (1) RS52053B (pt)
RU (1) RU2406502C2 (pt)
SI (1) SI2029110T1 (pt)
WO (1) WO2007141308A1 (pt)
ZA (1) ZA200810345B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR065720A1 (es) 2007-03-14 2009-06-24 Tibotec Pharm Ltd Polvos para reconstitucion que comprenden rilpivirina dispersos en ciertos polimeros. uso. proceso.
EP2263671B1 (en) * 2008-04-02 2016-07-20 Astellas Pharma Inc. Amide derivative-containing pharmaceutical composition
EP2306980A2 (en) * 2008-06-30 2011-04-13 Tibotec Pharmaceuticals Powders for reconstitution
US8703786B2 (en) * 2011-12-07 2014-04-22 Texas Southern University Etravirine formulations and uses thereof
CN104684545B (zh) * 2012-09-27 2018-04-03 巴斯夫欧洲公司 包含至少一种水溶性维生素e衍生物和至少一种亲水聚合物的储存稳定的无粉尘均质颗粒状配制剂
WO2019216700A1 (ko) * 2018-05-11 2019-11-14 주식회사 삼양사 고체 분산체, 이의 제조 방법, 이를 이용한 사슬 연장된 폴리우레탄 및 이를 포함하는 에폭시 수지 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2920956B2 (ja) * 1989-10-06 1999-07-19 藤沢薬品工業株式会社 ニルバジピン含有持続性錠剤
US6395303B1 (en) 1996-06-10 2002-05-28 Edward Mendell Co., Inc. Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
JPH107558A (ja) * 1996-06-19 1998-01-13 Eisai Co Ltd 溶解性改善製剤
SK287270B6 (sk) * 1998-11-10 2010-05-07 Janssen Pharmaceutica N. V. Derivát pyrimidínu
ATE400252T1 (de) * 1999-02-10 2008-07-15 Pfizer Prod Inc Pharmazeutische feste dispersionen
DE19945982A1 (de) 1999-09-24 2001-03-29 Knoll Ag Geschwindigkeitsbestimmte Partikel
TR200200763T2 (tr) * 1999-09-24 2003-09-22 Janssen Pharmaceutica N.V. Antiviral bileşimler
US6531158B1 (en) * 2000-08-09 2003-03-11 Impax Laboratories, Inc. Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
BR0307515A (pt) * 2002-02-01 2004-12-07 Pfizer Prod Inc Método para fabricar dispersões de drogas amorfas sólidas secas por aspersão homogêneas usando bicos de pressão
WO2004050068A1 (en) * 2002-11-29 2004-06-17 Janssen Pharmaceutica N.V. Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
EP1575563B1 (en) * 2002-12-19 2007-02-14 Pharmacia Corporation Non-hygroscopic formulation comprising a hydroscopic drug
ES2667668T3 (es) * 2003-07-17 2018-05-14 Janssen Sciences Ireland Uc Procedimiento para preparar partículas que contienen un antiviral
BRPI0417492A (pt) * 2003-12-09 2007-05-29 Pfizer composições compreendendo um inibidor de protease de hiv

Also Published As

Publication number Publication date
SI2029110T1 (sl) 2012-01-31
AU2007255418B2 (en) 2010-12-23
NO20090061L (no) 2009-01-06
CN101453989B (zh) 2012-06-13
HK1129579A1 (en) 2009-12-04
PL2029110T3 (pl) 2012-03-30
ATE522202T1 (de) 2011-09-15
AU2007255418A1 (en) 2007-12-13
BRPI0712346A2 (pt) 2012-07-17
RU2406502C2 (ru) 2010-12-20
CA2651665C (en) 2010-04-27
BRPI0712346B1 (pt) 2020-09-29
WO2007141308A1 (en) 2007-12-13
MX2008015686A (es) 2009-01-12
EP2029110B1 (en) 2011-08-31
RU2008152411A (ru) 2010-07-20
NO343652B1 (no) 2019-04-29
KR101179905B1 (ko) 2012-09-07
US20120208834A1 (en) 2012-08-16
CN101453989A (zh) 2009-06-10
DK2029110T3 (da) 2011-12-19
US20090197903A1 (en) 2009-08-06
JP5089685B2 (ja) 2012-12-05
IL195710A (en) 2014-02-27
ECSP088938A (es) 2009-01-30
ZA200810345B (en) 2012-05-30
ES2372983T3 (es) 2012-01-30
CY1112154T1 (el) 2015-12-09
CA2651665A1 (en) 2007-12-13
NZ572702A (en) 2011-09-30
KR20090024131A (ko) 2009-03-06
US9603803B2 (en) 2017-03-28
EP2029110A1 (en) 2009-03-04
BRPI0712346B8 (pt) 2021-05-25
JP2009539804A (ja) 2009-11-19
ME01305B (me) 2012-04-30
IL195710A0 (en) 2009-09-01
RS52053B (sr) 2012-04-30
PT2029110E (pt) 2011-11-23
AU2007255418C1 (en) 2011-08-18

Similar Documents

Publication Publication Date Title
HRP20110883T1 (hr) Postupak za pripremanje raspršivanjem osušenih formulacija tmc125
Rani et al. Improvement of antihyperglycemic activity of nano-thymoquinone in rat model of type-2 diabetes
Li et al. In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets
AU2018253545A1 (en) Microcrystalline diketopiperazine compositions and methods
Smeets et al. Amorphous solid dispersions of darunavir: Comparison between spray drying and electrospraying
JP2012236837A5 (pt)
Muthuselvi et al. Simple coacervates of zein to encapsulate Gitoxin
HRP20241719T1 (hr) Antitumorske smjese
NZ596610A (en) A poorly soluble drug containing microsphere with improved bioavailability and method of preparing the same
WO2011041395A3 (en) Silk nanospheres and microspheres and methods of making same
JP2017536401A5 (pt)
WO2005025535A3 (en) Methods for preparing pharmaceutical compositions
RU2012157685A (ru) Твердая дисперсия толваптана и способ ее получения
Chen et al. Generation of porous poly-L-lactide microspheres by emulsion-combined precipitation with a compressed CO 2 antisolvent process
Yang et al. Sustained drug release from electrostatic powder coated tablets with ultrafine ethylcellulose powders
EP1847260A3 (en) Solid dispersion preparation
HRP20210237T1 (hr) Postupak za proizvodnju stabilnih, amorfnih hibridnih nanočestica koje sadrže barem jedan inhibitor proteinske kinaze i barem jedan polimerni sastojak koji stabilizira i tvori matricu
CN102462667B (zh) 一种硫酸氢氯吡格雷片剂
KR101218428B1 (ko) 막유화법을 이용한 실리마린 경구용 고형제제 조성물 및 그 제조방법
CN104523638B (zh) 含有草酸艾司西酞普兰的片剂及其制备方法
KR101212310B1 (ko) 건식 마크로 비쥬얼 캡슐의 제조방법, 이로부터 제조된 건식 마크로 비쥬얼 캡슐 및 이를 포함하는 화장료 조성물
CN113577029A (zh) 具有改良溶出性质和表观溶解度的药物组合物及其制备方法
Lee et al. Effect of pH adjustment and ratio of oppositely charged polymers on the mechanistic performance and sustained release of volatile perfume in interpolyelectrolyte complex microcapsules
CN105395508B (zh) 一种洛芬待因复方制剂及其制备方法
CN115363023A (zh) 一种高效农药递送体系的制备方法